Advertisement
Screener

SIGNPATH PHARMA, INC. Net Income (Loss) Available to Common Stockholders, Basic

SIGNPATH PHARMA, INC. Net Income (Loss) Available to Common Stockholders, Basic

SIGNPATH PHARMA, INC. reported Net Income (Loss) Available to Common Stockholders, Basic of -$894.33 thousand for the 3-month period ending 2016-06-30, per its 10-Q filed 2016-08-15.

Discontinued › Income Statement › Net Income

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2016-08-15

  • SIGNPATH PHARMA, INC. net income (loss) available to common stockholders, basic for the quarter ending 2016-06-30 was -$894.33K.
  • SIGNPATH PHARMA, INC. net income (loss) available to common stockholders, basic for the quarter ending 2016-03-31 was -$600.89K.
  • SIGNPATH PHARMA, INC. net income (loss) available to common stockholders, basic for the quarter ending 2015-12-31 was -$471.06K.
  • SIGNPATH PHARMA, INC. net income (loss) available to common stockholders, basic for the quarter ending 2015-09-30 was -$671.89K.
  • SIGNPATH PHARMA, INC. net income (loss) available to common stockholders, basic for fiscal 2015 was -$2.40M.
  • SIGNPATH PHARMA, INC. net income (loss) available to common stockholders, basic for fiscal 2014 was -$3.39M.
Period endNet Income (Loss) Available to Common Stockholders, Basic 3 monthNet Income (Loss) Available to Common Stockholders, Basic 6 monthNet Income (Loss) Available to Common Stockholders, Basic 9 monthNet Income (Loss) Available to Common Stockholders, Basic 12 month
2016-06-30-$894.33K
10-Q · filed 2016-08-15
-$1.50M
10-Q · filed 2016-08-15
-$1.97M
derived: sum of 3 quarters · filed 2016-08-15
-$2.64M
derived: sum of 4 quarters · filed 2016-08-15
2016-03-31-$600.89K
10-Q · filed 2016-05-16
-$1.07M
derived: sum of 2 quarters · filed 2016-05-16
-$1.74M
derived: sum of 3 quarters · filed 2016-05-16
-$2.37M
derived: sum of 4 quarters · filed 2016-08-15
2015-12-31-$471.06K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-08
-$1.14M
derived: sum of 2 quarters · filed 2016-04-08
-$1.77M
derived: sum of 3 quarters · filed 2016-08-15
-$2.40M
10-K · filed 2016-04-08
2015-09-30-$671.89K
10-Q · filed 2015-11-16
-$1.30M
derived: sum of 2 quarters · filed 2016-08-15
-$1.92M
10-Q · filed 2015-11-16
-$2.71M
derived: sum of 4 quarters · filed 2016-08-15
2015-06-30-$629.76K
10-Q · filed 2016-08-15
-$1.25M
10-Q · filed 2016-08-15
-$2.03M
derived: sum of 3 quarters · filed 2016-08-15
-$3.16M
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31-$622.79K
10-Q · filed 2016-05-16
-$1.40M
derived: sum of 2 quarters · filed 2016-05-16
-$2.53M
derived: sum of 3 quarters · filed 2016-05-16
-$3.49M
derived: sum of 4 quarters · filed 2016-05-16
2014-12-31-$781.56K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-08
-$1.91M
derived: sum of 2 quarters · filed 2016-04-08
-$2.86M
derived: sum of 3 quarters · filed 2016-04-08
-$3.39M
10-K · filed 2016-04-08
2014-09-30-$1.12M
10-Q · filed 2015-11-16
-$2.08M
derived: sum of 2 quarters · filed 2015-11-16
-$2.61M
10-Q · filed 2015-11-16
2014-06-30-$958.71K
10-Q · filed 2015-08-14
-$1.16M
10-Q · filed 2015-08-14